Catalyst rises on upbeat 2025 revenue forecast, quarterly results beat

Catalyst Pharmaceuticals

27/02/2025 19:02

** Shares of drugmaker Catalyst Pharmaceuticals CPRX.O rise 7.9% to $22.21

** Company late on Wednesday forecast 2025 revenue in the range of $545 million to $565 millionn, analysts on average expect revenue to be $556.9 million, as per data compiled by LSEG

** CPRX posted fourth-quarter revenue of $141.8 million, beating analysts' estimate of $134.2 million

** Reported adj quarterly profit of 70 cents/share vs analysts' estimate of 34 cents/share

** Stock has risen 41.1% in the past 12 months

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))